The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer
暂无分享,去创建一个
P. Li | Ying Feng | Yifei Liu | Q. Mao | Wanjiang Xue | Zhi-wei Wang | Yibing Guo | Fei Wang | Peng Li
[1] Ning Zhang,et al. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway , 2016, Oncogene.
[2] P. Li,et al. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer , 2016, Tumor Biology.
[3] P. Li,et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma , 2015, Oncotarget.
[4] Joon-Oh Park,et al. Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer , 2015, Translational oncology.
[5] T. Tahara,et al. DNA methylation as a molecular biomarker in gastric cancer. , 2015, Epigenomics.
[6] J. Herman,et al. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel , 2015, Oncotarget.
[7] M. Plummer,et al. Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.
[8] Jun Yu,et al. Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer. , 2014, American Journal of Cancer Research.
[9] M. May. Statistics: Attacking an epidemic , 2014, Nature.
[10] A. Kaneda,et al. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. , 2014, World journal of gastroenterology.
[11] W. Meng,et al. Helicobacter pylori-induced gastric inflammation and gastric cancer. , 2014, Cancer letters.
[12] Qiang Sun,et al. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer. , 2014, Oncology reports.
[13] D. Ilson. Angiogenesis in gastric cancer: hitting the target? , 2014, The Lancet.
[14] Satoshi Morita,et al. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. , 2013, Journal of the National Cancer Institute.
[15] Peng Hou,et al. Gene methylation in gastric cancer. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[16] A. Thompson,et al. Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma. , 2013, The Journal of investigative dermatology.
[17] Xudong Xu,et al. RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer. , 2013, Biochemical and biophysical research communications.
[18] R. Burbano,et al. DNA and histone methylation in gastric carcinogenesis. , 2013, World journal of gastroenterology.
[19] I. Talaat,et al. Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer , 2012, Journal of clinical laboratory analysis.
[20] R. Dammann,et al. Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma , 2012, The Prostate.
[21] Bin Tean Teh,et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.
[22] A. Enk,et al. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi. , 2012, The Journal of investigative dermatology.
[23] Jun Yu,et al. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer , 2012, Cancer.
[24] Emma Donald,et al. Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples , 2012, Clinical medicine insights. Pathology.
[25] V. Hill,et al. Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis , 2011, Oncogene.
[26] Hong Lin,et al. Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas. , 2010, Neuro-oncology.
[27] R. Dammann,et al. Frequent epigenetic inactivation of RASSF10 in thyroid cancer , 2009, Epigenetics.
[28] Raffaella Chiaramonte,et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias , 2009, Molecular Cancer.
[29] C. Sakakura,et al. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. , 2009, Anticancer research.
[30] M. T. McCabe,et al. Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications , 2009, Clinical Cancer Research.
[31] D. Roukos,et al. Epigenetics in Gastric Cancer: Challenges for Clinical Implications , 2009, Annals of Surgical Oncology.
[32] Ren-Min Zhu,et al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. , 2008, World journal of gastroenterology.
[33] Mohammad Reza Abbaszadegan,et al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. , 2008, World journal of gastroenterology.
[34] A. Chalmers,et al. RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. , 2008, Molecular biology of the cell.
[35] W. Holzgreve,et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. , 2008, Anticancer research.
[36] T. Brzozowski,et al. Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[37] T. Brzozowski,et al. Gastric cancer and Helicobacter pylori infection. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[38] Nobuyuki Tani,et al. Correlation between serum DNA methylation and prognosis in gastric cancer patients. , 2006, Anticancer research.
[39] F. Chan,et al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer , 2005, British Journal of Cancer.
[40] D. Roder,et al. The epidemiology of gastric cancer , 2002, Gastric Cancer.
[41] I. Pak,et al. Gastric cancer and Helicobacter pylori infection , 1993, The British journal of surgery.
[42] Mohamad Amin Pourhoseingholi,et al. Burden of gastrointestinal cancer in Asia; an overview , 2015, Gastroenterology and hepatology from bed to bench.
[43] M. Coleman,et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.